ezetimibe has been researched along with Diabetic Glomerulosclerosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Ahmad, S; Alatar, AA; Alvi, SS; Chaturvedi, CP; Faisal, M; Khan, MS; Nabi, R; Shah, A | 1 |
Choby, B | 1 |
Almquist, T; Hjemdahl, P; Jacobson, SH; Mobarrez, F; Näsman, P | 1 |
Chaturvedi, CP; Chaudhary, DK; Ecelbarger, CM; Godbole, MM; Kumar, P; Mohan, A; Singh, RS; Tiwari, S | 1 |
Martin, PY; Saudan, P | 1 |
Arai, H; Matsubara, T; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
Amaha, M; Inoue, H; Kawagoe, Y; Maeda, S; Nakamura, T; Sato, E; Yamagishi, SI | 1 |
1 review(s) available for ezetimibe and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Diabetes Update: Prevention and Management of Diabetes Complications.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Depression; Diabetes Complications; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Dyslipidemias; Ezetimibe; Gastroparesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension | 2017 |
1 trial(s) available for ezetimibe and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
Topics: Aged; Anticholesteremic Agents; Azetidines; Case-Control Studies; Chemokine CCL2; Cross-Over Studies; Diabetes Mellitus; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Inflammation; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Renal Insufficiency, Chronic; Simvastatin; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2014 |
5 other study(ies) available for ezetimibe and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ezetimibe; Glycation End Products, Advanced; Maillard Reaction; Matrix Metalloproteinase 2; NF-kappa B; Oxidative Stress; Rats; Receptor for Advanced Glycation End Products; RNA, Messenger | 2023 |
Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor.
Topics: Animals; Atorvastatin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ezetimibe; Histone Deacetylase Inhibitors; Histone Deacetylases; Kidney; Male; Rats; Rats, Wistar | 2016 |
[Nephrology].
Topics: Anticholesteremic Agents; Azathioprine; Azetidines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Nephrology; Renal Dialysis; Secondary Prevention; Simvastatin; Treatment Outcome | 2012 |
Ezetimibe ameliorates early diabetic nephropathy in db/db mice.
Topics: Adiponectin; Adiposity; Animals; Anticholesteremic Agents; Azetidines; Blood Pressure; Blotting, Western; Body Weight; Creatinine; Diabetic Nephropathies; Ezetimibe; Glomerular Filtration Rate; Inflammation; Kidney Function Tests; Lipid Metabolism; Male; Metabolism, Inborn Errors; Mice; Mice, Obese; Obesity; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptors, Adiponectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2012 |
Ezetimibe reduces urinary albumin excretion in hypercholesterolaemic type 2 diabetes patients with microalbuminuria.
Topics: Albumins; Albuminuria; Azetidines; Blood Pressure; Body Mass Index; Chemokine CCL2; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ezetimibe; Female; Glycated Hemoglobin; Humans; Hypercholesterolemia; Male; Middle Aged; Triglycerides | 2012 |